risk stratification
The firm measures three proteins and inputs them into an algorithm to determine whether a patient will have a severe reaction to the SARS-CoV-2 virus.
Prenosis Aggregating Patient Biomarker, Clinical Data  to Build a Better Sepsis Diagnostic
Premium
The startup's algorithm combines biomarkers, patient demographics, and past medical histories to determine a patient's risk of severe sepsis.
Genetic Technologies, WashU Team up to Study Breast Cancer Risk in Woman of African Descent
The Australian company is working with the Institute for Public Health in St. Louis to expand the predictive capability of its GeneType breast cancer risk test.
The company is providing its 400-gene test through a physician-involved DTC model akin to Color and Invitae, but with content across a much larger swath of disease and health.
Volpara Adding Invitae Genetic Test Ordering to Breast Risk Software Platform
The companies have inked an agreement under which Volpara can integrate Invitae's test services into its suite of risk assessment products.